GSK settles in fraud case
GlaxoSmithKline will pay $150 million to settle claims it overcharged the U.S. government for anti-nausea drugs Zofran and Kytril.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.